Siemens Atellica CH Aspartate Aminotransferase P5P (ASTPLc) - HSA Registration DE0509613
Access comprehensive regulatory information for Siemens Atellica CH Aspartate Aminotransferase P5P (ASTPLc) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0509613 and owned by Siemens Healthcare Diagnostics Inc. The device was registered on August 02, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Atellicaยฎ CH Aspartate Aminotransferase P5P (ASTPLc) assay is for in vitro diagnostic use in the quantitative determination of aspartate aminotransferase activity in human serum and plasma (lithium heparin) on the Atellicaยฎ Analyzer. This assay is used to aid in the diagnosis and treatment of certain types of liver and heart disease.

